{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:59:02Z","timestamp":1790895542678,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T00:00:00Z","timestamp":1552435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["U01FD005279"],"award-info":[{"award-number":["U01FD005279"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002763","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T13:35:26Z","timestamp":1552484126000},"page":"e1002763","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":79,"title":["Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0299-7273","authenticated-orcid":true,"given":"Rishi J.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-6206","authenticated-orcid":true,"given":"Ameet","family":"Sarpatwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazleen F.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Lii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7329-3535","authenticated-orcid":true,"given":"James R.","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-2890","authenticated-orcid":true,"given":"Sarah K.","family":"Dutcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeid","family":"Raofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-798X","authenticated-orcid":true,"given":"Justin","family":"Bohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8867-2666","authenticated-orcid":true,"given":"Aaron S.","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Gagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"ref1","article-title":"The use of medicines in the United States: review of 2011","year":"2011"},{"issue":"21","key":"ref2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1001\/jama.2008.758","article-title":"Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis","volume":"300","author":"AS Kesselheim","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.7326\/M13-2942","article-title":"Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study","volume":"161","author":"JJ Gagne","year":"2014","journal-title":"Ann Intern Med"},{"issue":"Pt A","key":"ref4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.yebeh.2015.08.014","article-title":"Comparative effectiveness of generic versus brand-name antiepileptic medications","volume":"52","author":"JJ Gagne","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1377\/hlthaff.28.2.546","article-title":"Patients\u2019 perceptions of generic medications","volume":"28","author":"WH Shrank","year":"2009","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1345\/aph.1P389","article-title":"Physician perceptions about generic drugs","volume":"45","author":"WH Shrank","year":"2011","journal-title":"Ann Pharmacother"},{"key":"ref7","article-title":"Why do patients have doubts about generic drugs in Italy?","author":"L Pasina","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7326\/0003-4819-141-2-200407200-00011","article-title":"Allergic to generics","volume":"141","author":"TA Brennan","year":"2004","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamainternmed.2016.1688","article-title":"Prevalence and predictors of generic drug skepticism among physicians: results of a national survey","volume":"176","author":"AS Kesselheim","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/cpt.884","article-title":"Generic versions of narrow therapeutic index drugs: a national survey of pharmacists\u2019 substitution beliefs and practices","volume":"103","author":"A Sarpatwari","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11606-016-3612-7","article-title":"Variations in patients\u2019 perceptions and use of generic drugs: results of a National Survey","volume":"31","author":"AS Kesselheim","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/08870440903137170","article-title":"Lay views about medicines: the influence of the illness label for the use of generic versus brand","volume":"25","author":"MJ Figueiras","year":"2010","journal-title":"Psychol Health"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2014.8342","article-title":"Avoiding nocebo effects to optimize treatment outcome","volume":"312","author":"U Bingel","year":"2014","journal-title":"JAMA"},{"issue":"6359","key":"ref14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aap8488","article-title":"Nocebo effects can make you feel pain","volume":"358","author":"L Colloca","year":"2017","journal-title":"Science"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PSY.0b013e3182738826","article-title":"The effect of an apparent change to a branded or generic medication on drug effectiveness and side effects","volume":"75","author":"K Faasse","year":"2013","journal-title":"Psychosom Med"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/aje\/kwi192","article-title":"Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration","volume":"162","author":"T Sturmer","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/cpt.591","article-title":"Comparison of outcomes following a switch from a brand to an authorized versus independent generic drug","volume":"103","author":"RA Hansen","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12646","article-title":"Brand vs generic adverse event reporting patterns: an authorized generic-controlled evaluation of cardiovascular medications","volume":"43","author":"Y Alatawi","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/cpt.81","article-title":"Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs","volume":"97","author":"J Bohn","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ahj.2004.02.013","article-title":"Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records","volume":"148","author":"Y Kiyota","year":"2004","journal-title":"Am Heart J"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/01.mlr.0000160417.39497.a9","article-title":"Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors","volume":"43","author":"E Birman-Deych","year":"2005","journal-title":"Med Care"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0895-4356(92)90047-Q","article-title":"Identification of fractures from computerized Medicare files","volume":"45","author":"WA Ray","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jamainternmed.2014.5294","article-title":"Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study","volume":"174","author":"SA Berkowitz","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jclinepi.2010.10.004","article-title":"A combined comorbidity score predicted mortality in elderly patients better than existing scores","volume":"64","author":"JJ Gagne","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwr364","article-title":"Effects of adjusting for instrumental variables on bias and precision of effect estimates","volume":"174","author":"JA Myers","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2307\/2533160","article-title":"Matching using estimated propensity scores: relating theory to practice","volume":"52","author":"DB Rubin","year":"1996","journal-title":"Biometrics"},{"issue":"Suppl 2","key":"ref27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/pds.3263","article-title":"One-to-many propensity score matching in cohort studies","volume":"21","author":"JA Rassen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejim.2014.08.002","article-title":"Are generic and brand-name statins clinically equivalent? Evidence from a real data-base","volume":"25","author":"G Corrao","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"e003350","DOI":"10.1161\/JAHA.116.003350","article-title":"Comparative effectiveness of generic atorvastatin and Lipitor(R) in patients hospitalized with an acute coronary syndrome","volume":"5","author":"CA Jackevicius","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"KJ Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"k1180","DOI":"10.1136\/bmj.k1180","article-title":"Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study","volume":"361","author":"RJ Desai","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"S Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1377\/hlthaff.2012.0817","article-title":"Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings","volume":"31","author":"MA Fischer","year":"2012","journal-title":"Health Aff (Millwood)"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:14:09Z","timestamp":1588976049000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002763"}},"subtitle":[],"editor":[{"given":"Sanjay","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,13]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002763","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,13]]}}}